QualityStocks Stock Newsletters Archives - Page 643 of 1818

MondayNov 23, 2009 1:16 pm

An Opportunity to Get there First in the Media Space

It may appear to be a rather obvious statement, but getting to the investment before it actually goes up is the key to profit. One might call this misleading and sheer folly, but the opportunity does occasionally appear. In this instance, the opportunity discussed in this article may fall a bit out of QualityStocks’ guidelines but it may also be an opportunity for those that wish to invest in stocks pricier than what is generally featured by QualityStocks. To be so bold, we might call this opportunity the "Opra play." Opra Winfrey, a recognized media mogul, has been getting quite…

MondayNov 23, 2009 12:51 pm

Akeena Solar, Inc. (AKNS) Partners with Highland Solar Achieving Canadian Market Penetration

Akeena Solar Inc (AKNS), well-known for their Andalay AC power systems, which are stand-alone solar systems designed for the average home, announced a partnership with Highland Solar (HS) today, Monday, Nov. 23. HS, located in Ontario, will move at least 1.75 megawatts (MW) of the Andalay AC solar panels through 2010, via its local installers throughout Canada. CEO of AKNA Barry Cinnamon commented on the growth potential of rooftop solar systems in Canada, and hailed the partnership with HS for distribution of Andalay AC systems, saying of the product that it could help Canadians “lower their electricity bills with safe,…

MondayNov 23, 2009 12:44 pm

Cardio Vascular Medical Device Corp. (CVSL.OB) Applying for Patents in Europe, Canada, and Far East

Cardio Vascular Medical Device Corp., an Israeli based developer of advanced cardiovascular surgery technologies, has announced that it will apply for additional patents for its proprietary steerable guidewire product for use in angioplasty procedures. The company already holds a U.S. patent for its innovative guidewire, but wants to obtain patents in Europe, Canada, and the Far East in order to penetrate a worldwide commercial marketplace for the life-saving angioplasty procedure. The steerable guidewire is applicable for all angioplasty procedures, and the potential market for related equipment exceeds $500 million. Angioplasty is now a common procedure, performed to widen narrowed or…

MondayNov 23, 2009 12:42 pm

NRG Energy, Inc. (NRG) Acquires California Photovoltaic Solar Project

Today, NRG Energy, Inc. announced that it has acquired the first and largest utility-scale photovoltaic Blythe Solar Project in California, through its wholly owned subsidiary NRG Solar LLC. The 21 megawatt project will be NRG’s first solar generation facility; NRG acquired the site from First Solar, Inc. (NASDAQ: FSLR). As part of the acquisition, NRG Solar has entered into an engineering, procurement and construction agreement with First Solar for completion and performance testing. Testing will commence later this month; the company expects the project to be completed by year’s end. Located in Riverside County, California, the solar PV field will…

MondayNov 23, 2009 9:31 am

MWW Automotive Group (MWWC.OB) Subsidiary Signs Major Distribution Agreement

MWW Automotive Group is a young corporation that has gained notoriety across the globe for producing and delivering their products, design and Class A painting services to automobile manufacturers and assembly lines across the world. Today, MWW announced that Modelworxx, its wholly owned subsidiary located in Germany, signed an executive agreement with Isomotive BV, which is the largest supplier for protective car accessories in the Netherlands. Isomotive BV develops and manufactures special functional impact side bars and running boards for an array of vehicles. These running boards and side bars on commercial vehicles are in special demand in Europe because…

MondayNov 23, 2009 9:23 am

Pashminadepot.com, Inc. Changes Name to SwissINSO Holding Inc. (SWHN.OB)

SwissINSO Holding Inc. (SWHN.OB), formerly PASH.OB, recently announced the company's reincorporation in Delaware on October 28, 2009, and new name change that reflects the previously disclosed acquisition of SwissINSO SA. This acquisition was completed on October 19, 2009. Effective immediately, SwissINSO is trading under the ticker symbol SWHN and CUSIP number 87101R105. Formed in 2006 and located in Lausanne, Switzerland, SwissINSO Holdings Inc. utilizes the company’s significant intellectual property assets to provide environmentally friendly solar energy solutions and related technology to meet growing global needs. The company’s goal is to become a world leader in turn-key solutions using renewable energy…

FridayNov 20, 2009 2:34 pm

Artfest International, Inc. (ARTS.OB) Announces Revenue & Profit Jumps

Artfest International Inc., the Dallas based art community marketing and services company, today announced financial results for the third quarter ending 9/30/09, including a huge jump in operating revenue. The company generated $896,404 in operating revenue for the quarter, as compared to $4,000 for the same quarter in 2008, representing an increase of 22,310%. The company also reported an important move into positive territory for net income, declaring a net income of $7,397 for the quarter, as compared to a net loss of $29,862 for the same quarter 2008. In addition, Artfest International experienced a jump in total assets. The…

FridayNov 20, 2009 2:28 pm

Soligenix Inc. (SNGX.OB) Taking Steps to Meet Challenges of Vaccine Technology and Biological Warfare

Soligenix Inc., formerly known as DOR BioPharma Inc., a late-stage biotechnology company, today announced it has formed a consortium to develop technology to enhance acting vaccines, including RiVax, the company’s proprietary vaccine for ricin toxin, which can be used as a biological weapon. Soligenix also announced it was awarded a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to continue this work. The announced consortium draws together industry and academic researchers from various disciplines, including the University of Colorado, the University of Kansas, and the Tulane…

FridayNov 20, 2009 2:26 pm

Genta Inc. (GETA.OB) Cancer Drug Shown Effective with Chemotherapy in Advanced Melanoma

Genta Inc. released the results from a pilot study on advanced melanoma incorporating the Company’s cancer drug Genasense(R) (oblimersen sodium). This study was featured earlier this week in a presentation at the World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers in Berlin, Germany, an international conference organized every year by a co-leader of the AGENDA trial, the European Association of Dermatologic Oncology (EADO). Genasense, delivered for the first time in a high-dose, 1-hour intravenous (IV) format, was used along with the most common melanoma drug temozolomide (Temodar(R); Schering Plough, Inc.), and a paclitaxel suspension (Abraxane(R); Abraxis Bioscience, Inc.). Using a standard…

FridayNov 20, 2009 2:23 pm

Biotel Inc. (BTEL) Reports Profitable Quarter

Biotel Inc. (BTEL) reported net income of $128,000, or $0.04 per diluted share, for the third quarter of 2009. This was down from the $328,000, or $0.11 per diluted share, reported a year earlier. Revenues in the quarter were reported at $3.2 million, up 3% from the $3.1 million reported in the third quarter of 2008. Steve Springrose, the CEO of Biotel Inc., said, “Biotel enjoyed strong sales and earnings through the first quarter and believes its upcoming new wireless event and MCT products have favorable attributes for the arrhythmia service market.” In April 2009, Biotel Inc. announced a merger…

Site Search

Company Search

Category: QualityStocks Stock Newsletters